Ku蛋白在膀胱癌组织中表达的免疫组织化学研究

魏晓龙, 郭和清, 严景民, 等. Ku蛋白在膀胱癌组织中表达的免疫组织化学研究[J]. 临床泌尿外科杂志, 2013, 28(10): 760-763.
引用本文: 魏晓龙, 郭和清, 严景民, 等. Ku蛋白在膀胱癌组织中表达的免疫组织化学研究[J]. 临床泌尿外科杂志, 2013, 28(10): 760-763.
WEI Xiaolong, GUO Heqing, YAN Jingmin, et al. Immunohistochemical study on the expression of Ku proteins in carcinoma of bladder[J]. J Clin Urol, 2013, 28(10): 760-763.
Citation: WEI Xiaolong, GUO Heqing, YAN Jingmin, et al. Immunohistochemical study on the expression of Ku proteins in carcinoma of bladder[J]. J Clin Urol, 2013, 28(10): 760-763.

Ku蛋白在膀胱癌组织中表达的免疫组织化学研究

详细信息
    通讯作者: 郭和清,E-mail:guoheqing@sina.com.cn
  • 中图分类号: R737.14

Immunohistochemical study on the expression of Ku proteins in carcinoma of bladder

More Information
  • 目的:研究Ku蛋白表达与膀胱癌发生、进展的关系。方法:应用SP法对98例行经尿道膀胱肿瘤电切术(TURBT)、根治性膀胱切除术的膀胱组织标本进行免疫组织化学染色;应用形态计量学分析方法结合临床相关病理资料分析Ku蛋白表达与膀胱癌肿瘤相关指标的关系。结果:98例膀胱癌组织中Ku蛋白总阳性表达数为79例(80.61%)。67例非肌层浸润性膀胱癌组织中Ku蛋白阳性表达数为60例(89.55%),31例肌层浸润性膀胱癌中Ku蛋白阳性表达数为19例(61.29%),两者差异有显著统计学意义(P<0.01)。图像分析结果:肌层浸润性膀胱癌组(2 453.05±221.24)和非肌层浸润性膀胱癌组(4 349.41±307.20)之间积分光密度的差异有显著统计学意义(P<0.01)。肿瘤组织(3 605.67±1 024.80)与癌旁组织(396.84±60.24)之间积分光密度的差异度亦有显著统计学意义(P<0.01)。结论:Ku蛋白可能在膀胱癌进展的过程中发挥着重要作用。早期Ku蛋白表达增加是膀胱癌发生的一个重要因素。晚期Ku蛋白表达下调与膀胱癌的侵袭性密切相关。
  • 加载中
  • [1]

    Mimori T, Akizuki M, Yamagata H, et al. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap[J]. J Clin Invest, 1981, 68(3):611-620.

    [2]

    Lieber M R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway[J]. Annu Rev Biochem, 2010, 79:181-211.

    [3]

    Grob P, Zhang T T, Hannah R, et al. Electron microscopy visualization of DNA-protein complexes formed by Ku and DNA ligase IV[J]. DNA Repair, 2012, 11 (1):74-81.

    [4]

    Fleck O, Nielsen O. DNA repair[J].J Cell Sci, 2004, 117(Pt 4):515-517.

    [5]

    Sibanda B L, Chirgadze D Y, Blundell T L. Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats[J]. Nature, 2010, 463(7277):118-121.

    [6]

    Douglas P, Cui X P, Block W D, et al. The DNA-dependent protein kinase catalytic subunit is phosphorylated in vivo on threonine 3950, a highly conserved amino acid in the protein kinase domain[J]. Mol Cell Biol, 2007, 27(5):1581-1591.

    [7]

    Liu Q H, Li L M, Wang J F. Expression and significance of hTERT, P53 and Ki-67 in astrocytoma by tissue microarray[J]. Chin Remedies Clin, 2005, 5(5):354-356.

    [8]

    Lu H, Shimazaki N, Raval P, et al. A biochemically defined system for coding joint formation in V(D)J recombination[J]. Mol Cell, 2008, 31(4):485-497.

    [9]

    Mahaney B L, Meek K, Lees-Miller S P. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining[J]. Biochem, 2009, 417(3):639-650.

    [10]

    Neal J A, Dang V, Douglas P, et al. Inhibition of homologous recombination by DNA-dependent protein kinase requires kinase activity, is titratable, and is modulated by autophosphorylation[J]. Mol Cell Biol, 2011, 31(8):1719-1733.

    [11]

    Hammel M, Yu Y, Mahaney B L, et al. Ku and DNA-dependent protein kinase dynamic conformations and assembly regulate DNA binding and the initial non-homologous end joining complex[J].J Biol Chem, 2010, 285(2):1414-1423.

    [12]

    Yu Y, Mahaney B L, Yano K, et al. DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for repair of DNA double strand breaks[J]. DNA Repair, 2008, 7(10):1680-1692.

    [13]

    Lim D S, Vogel H, Willerford D M, et al. Analysis of Ku80-mutant mice and cells with deficient levels of p53[J]. Mol Cell Biol, 2000, 20(11):3772-3780.

    [14]

    Gaymes T J, Mufti G J, Rassool F V. Myeloid leukemias have increased activity of the non-homologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer[J]. Cancer Res, 2002, 62(10):2791-2797.

    [15]

    Korabiowska M, Tscherny M, Grohmann U, et al. Decreased expression of Ku70/Ku80 proteins in malignant melanomas of the oral cavity[J]. Anticancer Res, 2002, 22(1A):193-196.

    [16]

    Pucci S, Mazzarelli P, Rabitti C, et a1. Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies[J]. Oncogene, 2001, 20(6):739-747.

    [17]

    Komuro Y, Watanabe T, Hosoi Y, et al. The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma[J]. Cancer, 2002, 95(6):1199-1205.

    [18]

    Kinzler K W, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers[J]. Nature, 1997, 386(6627):761, 763.

    [19]

    Difilippantonio M J, Zhu J, Chen H T, et al. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation[J]. Nature, 2000, 404(6777):510-514.

    [20]

    Holgersson A, Erdal H, Nilsson A, et al. Expression of DNA-PKcs and Ku86, but not Ku70, differs between lymphoid malignancies[J]. Exp Mol Pathol, 2004, 77(1):1-6.

    [21]

    Rigas B, Borgo S, Elhosseiny A, et al. Decreased exp ression of DNA-dependent protein kinase, a DNA repair protein, during human colon carcinogenesis[J]. Cancer Res, 2001, 61(23):8381-8384.

    [22]

    Stronati L, Gensabella G, Lamberti C, et al. Expression and DNA binding activity of the Ku heterodimer in bladder carcinoma[J]. Cancer, 2001, 92(9):2484-2492.

  • 加载中
计量
  • 文章访问数:  25
  • PDF下载数:  72
  • 施引文献:  0
出版历程
收稿日期:  2013-05-20

目录